| Date | Time | Source | Headline | Symbol | Company |
| 06/04/2024 | 1:08PM | iHub Newswire | FeaturedElement79 Gold Corp Continues Fostering Local Community Engagement | | |
| 03/05/2012 | 7:00AM | Marketwired | OncoSec Medical (ONCS) Targets $47 Billion Cancer Market | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 03/05/2012 | 2:00AM | PR Newswire (US) | Onyx Pharmaceuticals International GmbH Appoints Luigi Costa as Vice President of Europe | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/29/2012 | 1:26PM | Zacks | Onyx Pharma's MM Candidate Advances - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/27/2012 | 5:18PM | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/27/2012 | 8:20AM | Marketwired | Breakthrough Cancer Treatments Helping Death Rates Fall | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/24/2012 | 9:30AM | Zacks | Onyx Beats; Says 2012 Vital - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/22/2012 | 4:30PM | PR Newswire (US) | Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Rela... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/22/2012 | 4:27PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/22/2012 | 4:15PM | PR Newswire (US) | Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2011 Financial Results | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/21/2012 | 4:00PM | PR Newswire (US) | Onyx Pharmaceuticals to Present at Upcoming Investor Conferences | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/16/2012 | 5:02PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/14/2012 | 4:55PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/14/2012 | 10:01AM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/13/2012 | 11:06AM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/10/2012 | 9:00AM | Marketwired | Conditions of Growth, Economic Analysis - Research Report on Onyx Pharmaceuticals, Inc. and Qiagen NV | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/09/2012 | 4:00PM | PR Newswire (US) | Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results Teleconference and Webcast | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/08/2012 | 5:19PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/03/2012 | 5:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 02/03/2012 | 5:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 01/27/2012 | 2:45PM | Dow Jones News | UPDATE: FDA Approves Pfizer's Inlyta For Advanced Kidney Cancer | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 01/18/2012 | 5:45AM | Zacks | Bayer/Onyx Announce Cancer Data - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 01/17/2012 | 6:21PM | PR Newswire (US) | Phase 3 Data Show Bayer's Investigational Compound Regorafenib (BAY 73-4506) Met Primary Endpoint Showing Statistically Signi... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 01/10/2012 | 5:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 01/05/2012 | 6:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 01/03/2012 | 4:00PM | PR Newswire (US) | Onyx Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 12/23/2011 | 4:30AM | Zacks | Pipeline Setback at Bristol-Myers - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 12/22/2011 | 5:24PM | Dow Jones News | Bristol-Myers Drug Misses Survival Goal In Liver Cancer Trial | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 12/14/2011 | 9:00AM | PR Newswire (US) | Multiple Myeloma Research Foundation (MMRF) and Onyx Pharmaceuticals Announce Multi-Year Collaboration to Accelerate Personal... | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
| 12/13/2011 | 4:00AM | Zacks | Standard FDA Review for Onyx Drug - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |